Charles River is a global leader in providing products and services that support pharmaceutical and biotechnology companies, government agencies, and academic institutions in accelerating research and drug development. With a presence in over 150 facilities across 21 countries, Charles River has a longstanding history of contributing to the...
With over 35 years of experience, SeerPharma has been at the forefront of supporting cutting-edge medical device and medtech companies in Quality and GxP compliance. Over the years, we have witnessed the rapid rise of implantables, neurotech, and diagnostic technologies—areas that continue to shape the future of healthcare.
SeerPharma is pleased to announce a strategic partnership with QACV Consulting, enhancing our ability to support clients in the United States.
A decade ago, Duke-NUS Medical School in Singapore, established the Centre of Regulatory Excellence (CoRE) to enhance health products regulatory systems and competency across ASEAN and the broader Asia-Pacific region. CoRE is pivotal in supporting policy innovation and facilitating progress towards effective and efficient health product...
SeerPharma is proud to sponsor and participate in the 2nd Annual Eye & Tissue Banking Conference, hosted by the Eye Bank Association of Australia and New Zealand (EBAANZ).
The power to control one’s health is shifting more each day from life sciences companies and healthcare organisations to the consumers themselves. Never have consumers had so many options for personalised therapies or greater control over their well-being.
Artificial Intelligence (AI) and emerging technologies are rapidly advancing, influencing every aspect of business operations, including the biotechnology and life sciences sectors.
SeerPharma has a long-standing reputation for helping pharmaceutical and medical device companies establish new or upgrade existing GMP manufacturing facilities. The team is currently engaged in multiple facility projects across the APAC region, working on complex facility projects involving the manufacture of:
SeerPharma has identified a growing demand from cell and gene therapy manufacturers across the APAC region for expert advisory services and tailored training in Good Manufacturing Practice (GMP). Recognising this need, our team has expanded its capabilities in this specialised area, culminating in the design, development and delivery of a GMP...
INFOGRAPHIC: A snapshot of how SeerPharma supported its customers with Quality and GMP Best-Practices in 2024 by providing QA & GMP Consulting, Auditing & Training services as well as MasterControl solutions "Qx" electronic Quality Management Systems (eQMS) & "Mx" Manufacturing Execution Systems (MES) with electronic Batch Records (eBR).
Copyright © SeerPharma
